Trial intelligence / Profile preview

Phase II trial of MK-8457 plus methotrexate in active rheumatoid arthritis

2012-000439-17Phase 2Terminated

Sponsor

Merck & Co.

Start

Mar 2012

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1